Dr. Reddy's Laboratories Limited
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Dr. Reddy's Laboratories Limited sits in the top decile of US sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count).
Dr. Reddy's Laboratories Limited: 52 sponsored US clinical trials, none currently recruiting.
Dr. Reddy's Laboratories Limited sponsors 52 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 51 completed. 10 of these trials are in Phase 3-4 (later-stage) and 42 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 6 trials.
Top-decile sponsor footprint
Dr. Reddy's Laboratories Limited ranks in the top decile of sponsors by registered trial count (#363 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
51 of 52 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
52 total, page 1 of 2
A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products
NCT04268771
Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma
NCT03976102
Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15
NCT03554772
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
NCT03421197
A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris
NCT03599193
A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris
NCT03341910
A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris
NCT03290027
A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks
NCT03292640
Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects
NCT03282838
A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
NCT03116698
DFN-11 Injection in Episodic Migraine With or Without Aura
NCT02569853
Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine
NCT02571049
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
NCT02572986
Pilot Study of DFN-11 Injection in Medication Overuse Headache
NCT02583425
Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults
NCT03051685
Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches
NCT02472418
DFN-02 Open Label Safety Study in Patients With Acute Migraine
NCT02279082
A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
NCT02173301
A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
NCT02060903
Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
NCT02062060
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
NCT02061813
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
NCT02062073
Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery
NCT01888367
A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
NCT02010333
Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation
NCT01674530
DFA-02 in Patients Undergoing Colorectal Surgery
NCT01496352
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
NCT01518699
An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
NCT01336647
Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions
NCT01264289
Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions
NCT01264302
Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed Conditions
NCT01506791
Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition
NCT01506037
Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition
NCT01506050
Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions
NCT01314352
Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.
NCT01314339
Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions
NCT01372345
Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
NCT01161979
Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
NCT01161966
Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions
NCT01372358
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions
NCT01581879
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions
NCT01581866
Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.
NCT01131897
Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions
NCT01132352
Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fed Condition
NCT01131975
Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fasting Condition
NCT01131949
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition
NCT01513720
Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition
NCT01513681
Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions
NCT01131923
Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition
NCT01888341
Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions
NCT01131936
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 30 |
| Phase 2 | 12 |
| Phase 3 | 10 |
Therapeutic Areas
How the Dr. Reddy's Laboratories Limited early-phase archive is shaped
52 indexed studies, none listed as recruiting (0% open); 51 completed (98%).
Phase mix: 10 late (III/IV) vs 42 early (I/II) (early-phase heavy).
Top condition: Healthy (6 trials), 8 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Dr. Reddy's Laboratories Limited: archived-pipeline peers nationwide
Peers matched on 52 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Dr. Reddy's Laboratories Limited sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 52 archived trials
- Albany Medical College · 52 trials · 13% recruiting
- Burzynski Research Institute · 52 trials · 0% recruiting
- PTC Therapeutics · 52 trials · 2% recruiting
- Spectrum Pharmaceuticals · 52 trials · 2% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Dr. Reddy's Laboratories Limited page
52 registered trials is a research-attention snapshot, not an endorsement of Dr. Reddy's Laboratories Limited or any single study.
- None of Dr. Reddy's Laboratories Limited's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy is the condition Dr. Reddy's Laboratories Limited studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Dr. Reddy's Laboratories Limited pipeline card: 52 registered trials from official public datasets.Report a data error.